MedTrace Logo

Nostalgia Intervention on Alleviating Loneliness Amongst Older Adults

NCT07288671 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 294

Last updated 2025-12-23

No results posted yet for this study

Summary

The proposed study will utilise a two-arm, cluster-randomised, waitlist-controlled trial to (1) examine the effects of the nostalgia intervention on loneliness, negative emotions, social connectedness, meaning in life and nostalgia amongst community-dwelling older adults in Hong Kong; (2) investigate whether the effect of the nostalgia intervention on loneliness is mediated by improvements in negative emotions, social connectedness and meaning in life; and (3) explore the experiences and perceptions of older adults participating in the nostalgia interventions, focusing on their views regarding the impact of the intervention on their loneliness.

Conditions

  • Loneliness

Interventions

BEHAVIORAL

Nostalgia intervention

Participants in the intervention group will receive the face-to-face nostalgia intervention weekly for 5 weeks (each session lasting approximately 90 minutes), with each group consisting of 5-8 older adults. The intervention consists of 5 sessions: Session 1 (understanding nostalgia and its benefits), Session 2-4 (music/ photos/ meaningful objects and nostalgia), Session 5 (reaffirming the benefits of nostalgia).

Sponsors & Collaborators

  • Chinese University of Hong Kong

    lead OTHER

Principal Investigators

  • Cho Lee Wong, PhD · The Nethersole School of Nursing, CUHK

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-09-01
Primary Completion
2028-06-30
Completion
2028-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07288671 on ClinicalTrials.gov